Table 3.
Clinical outcome after 3–6 months’ follow-up in relation to treatment strategies and blood volumes > or < 50 ml in 76 patients with a ruptured MCA aneurysm and an associated intraparenchymal hematoma
| > 50 ml, n (%) | < 50 ml, n (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Total | Clinical outcome | Total | Clinical outcome | |||||
| mRS 0–3 | mRS 4–5 | mRS 6 | mRS 0–3 | mRS 4–5 | mRS 6 | |||
| 14 (18) | 4 (29) | 3 (21) | 7 (50) | 62 (82) | 28 (45) | 12 (19) | 22 (35) | |
| No treatment | 3(21) | 0 | 0 | 3 (100) | 8 (13) | 1 (13) | 0 | 7 (88) |
| Coiling | 6 (43) | 2 (33) | 2 (33) | 2 (33) | 22 (35) | 13 (59) | 6 (27) | 3 (14) |
| No decompression | 0 | 0 | 0 | 0 | 10 (45) | 9 (90) | 1 (10) | 0 |
| Decompression* | 6 (100) | 2 (33) | 2 (33) | 2 (33) | 12 (55) | 4 (33) | 5 (42) | 3 (25) |
| Clipping | 5 (36) | 2 (40) | 1 (20) | 2 (40) | 32 (52) | 14 (44) | 6 (19) | 12 (38) |
| No decompression | 0 | 0 | 0 | 0 | 8 (25) | 7 (88) | 0 | 1 (13) |
| Decompression* | 5 (100) | 2 (40) | 1 (20) | 2 (40) | 24 (75) | 7 (29) | 6 (25) | 11 (46) |
No statistical significant differences were found between all analyzed variables
mRS modified Rankin scale
*With or without clot removal